On September 22, President Donald Trump announced at the White House, alongside Health and Human Services Secretary Robert F. Kennedy Jr. and CMS Administrator Dr. Mehmet Oz, that the FDA would notify physicians of a possible association between acetaminophen use during pregnancy and increased risk of autism in children, and would begin updating safety labeling for acetaminophen products, most notably Tylenol. Trump stated that pregnant women should limit acetaminophen to cases of high fever only and avoid giving it to babies, citing skyrocketing autism rates (now 1 in 31 U.S. children).

This warning came after HHS, FDA, and NIH reviewed dozens of existing high-profile studies by established researchers, who found a probable association between acetaminophen use during pregnancy and autis

See Full Page